Back to results
US 2017/0360817 A1Published application
Use of aminoglycoside analogs in the treatment of rett syndrome
AssigneeEloxx Pharmaceuticals Ltd.
InventorsTimor BAASOV, Shmuel TUVIA, Dori PELLED
Life of this patent
Estimating the term…
Abstract
Compounds, methods and uses of pseudo-trisaccharide aminoglycosides represented by the general formula I: or a pharmaceutically acceptable salt thereof, wherein R1 is selected from the group consisting of alkyl, cycloalkyl and aryl; and all other variables and features are as described in the specification, in the treatment of Rett syndrome are disclosed.
Claims17
A method of treating Rett syndrome in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of a compound represented by formula I:
- or a pharmaceutically acceptable salt thereof,
- wherein:
- R1 is selected from the group consisting of alkyl, cycloalkyl and aryl;
- R2 is hydrogen or (S)-4-amino-2-hydroxybutyryl (AHB);
- R3 is selected from the group consisting of hydrogen, alkyl, cycloalkyl and aryl;
- a stereo-configuration of position 5″ is an R configuration or an S configuration;
- and
- a stereo-configuration of position 6′, when chiral, is an R configuration or an S configuration.
5 more elements
2-4. (canceled)
Dependencies are inferred from the claim text.